 |
 |
Error during command authentication.
Error - unable to initiate communication with LISTSERV (errno=111). The server is probably not started.
A new book on the GDNF clinical trial halt by Amgen has just been published by investigative journalist Nick Nelson. The title is "Monkeys in the Middle : How One Drug Company Kept a Parkinson's Disease Breakthrough Out of Reach". It's available on Amazon, see: http://www.amazon.com/Monkeys-Middle-Company-Parkinsons-Breakthrough/dp/1419696556/ref=sr_1_1?ie=UTF8&s=books&qid=1212156521&sr=8-1 About the book: "Some said it a miracle drug; others called it the cure. A drug known simply as "GDNF" seemed to do the impossible by actually reversing the effects of Parkinson's disease. The miracle ended in the fall of 2004 when Amgen Inc. abruptly halted clinical trials of GDNF and denied access to the drug. In "Monkeys in the Middle", investigative reporter Nick Nelson recounts the true story of the brave patients who took on the world's biggest biotechnology company for the right to be kept alive. " (from Amazon) For more about the GDNF controversy see: http://www.pdpipeline.org/advocacy/gdnf_table.htm ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn